ClinicalTrials.Veeva

Menu

Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study

I

Institute for Digital Medicine (WisDM)

Status

Not yet enrolling

Conditions

Healthy
Digital Health
Intermittent Fasting

Treatments

Device: Wearables
Behavioral: Glucose-Ketone Index (GKI) monitoring
Other: Interviews
Behavioral: Fitness intervention
Dietary Supplement: Supplements
Behavioral: Generative AI
Behavioral: Mediterranean-inspired diet
Diagnostic Test: Stool tests
Device: Airofit
Other: Digital dynamometer
Behavioral: 18h fasting
Behavioral: 48h fasting
Behavioral: Continuous Glucose Monitoring (CGM)
Diagnostic Test: Saliva tests
Behavioral: Three meal phase
Behavioral: Cold & heat intervention
Diagnostic Test: Blood tests

Study type

Interventional

Funder types

Other

Identifiers

NCT06630637
HO_prospective

Details and patient eligibility

About

There is a growing interest in personalized health strategies, including diet, exercise, and fasting regimens, to enhance metabolic fitness. Recent research indicates that intermittent fasting (IF) is useful not only for weight management, but also for energy production and improvement of metabolic well-being.

IF can potentially reduce systemic inflammation and help to prevent chronic diseases. IF research can also help athletes sustain performance during fasting periods. This prospective study aims to investigate the effects of a human optimization program on an individual's metabolic health and overall well-being.

This research examines the correlations between continuous glucose monitoring, ketone measurement, exercise routines, heat/cold interventions, diet, supplements and intermittent fasting patterns. The study involves a single participant -the principal investigator- who will adhere to a personalized regimen involving wearable monitoring of metabolic changes, training and intermittent fasting. This research seeks to understand the potential relationships between these factors, contributing to the emerging knowledge on individualized health optimization.

Enrollment

1 estimated patient

Sex

Male

Ages

21+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • The principal investigator is the sole participant in this N-of-1 trial: a healthy individual with no chronic diseases or conditions affecting metabolic health.

Exclusion criteria

  • The principal investigator is the sole participant in this N-of-1 trial.

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

1 participants in 1 patient group

Personalized Health Intervention Arm
Experimental group
Description:
This arm involves the the single participant following a personalized regimen that includes intermittent fasting, exercise routines, heat/cold interventions, diet modifications, and supplementation. The participant will engage in continuous monitoring of metabolic changes using wearable technology, continuous glucose monitoring, and ketone measurements, along with blood, saliva, and stool lab tests. The goal is to assess the effects of these interventions on metabolic health and overall well-being, identifying potential trends and correlations throughout the study period.
Treatment:
Diagnostic Test: Blood tests
Behavioral: Cold & heat intervention
Behavioral: Three meal phase
Diagnostic Test: Saliva tests
Behavioral: 48h fasting
Behavioral: Continuous Glucose Monitoring (CGM)
Behavioral: 18h fasting
Other: Digital dynamometer
Device: Airofit
Behavioral: Mediterranean-inspired diet
Diagnostic Test: Stool tests
Behavioral: Generative AI
Dietary Supplement: Supplements
Behavioral: Fitness intervention
Other: Interviews
Behavioral: Glucose-Ketone Index (GKI) monitoring
Device: Wearables

Trial contacts and locations

0

Loading...

Central trial contact

Peter Wang, PhD; Xavier Tadeo, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems